Vontobel Holding
MDGL icon

Vontobel Holding’s Madrigal Pharmaceuticals MDGL Stock Holding History

Vontobel Holding’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,091
Closed -$252K – 1110
2023
Q2 		$252K Buy
+1,091
New +$295K ﹤0.01% 950
2023
Q1 		– Sell
-809
Closed -$235K – 1112
2022
Q4 		$235K Buy
+809
New +$79.1K ﹤0.01% 949

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vontobel Holding's MDGL Position: Q3 2023 in Review

Vontobel Holding sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2023, closing a stake of 1,091 shares — an estimated $252K sold.

Vontobel Holding first reported a position in MDGL in Q4 2022 and held it in 2 quarters. The position peaked at $252K in Q2 2023. 205 funds tracked by Wall St. Rank hold MDGL as of Q3 2023.

  • Vontobel Holding reported no remaining Madrigal Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Vontobel Holding sold 1,091 Madrigal Pharmaceuticals shares in Q3 2023, an estimated $252K.
  • Vontobel Holding first reported a position in Madrigal Pharmaceuticals in Q4 2022 and held it in 2 quarters.
  • Vontobel Holding's Madrigal Pharmaceuticals position peaked at $252K in Q2 2023.
  • 205 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2023.

Based on Vontobel Holding's 13F filing for Q3 2023, filed 11 Oct 2023.